An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' Trial
Public ClinicalTrials.gov record NCT00754624. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Four-year, Safety and Tolerability, Open-Label, "Follow on" Trial Evaluating Technosphere® Insulin in Subjects With Type 2 Diabetes Mellitus.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Safety Follow-Up Trial to PDC-INS-0008 and MKC-TI-005
Study identification
- NCT ID
- NCT00754624
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 229 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2004 (Type not available)
- Primary completion
- Jun 2008 (Actual)
- Completion
- Oct 2008 (Actual)
- Last update posted
- Oct 16, 2014
2004 – 2008
United States locations
- U.S. sites
- 17
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dorothy L & James E Frank Diabetes Research Institute | San Mateo | California | 94401 | — |
| Sansum Medical Research Institute | Santa Barbara | California | 93105 | — |
| Alliance Medical Group of Greater Waterbury | Middlebury | Connecticut | 06762 | — |
| The Hospital of Central Connecticut | New Britain | Connecticut | 06050 | — |
| Soundview Research Associates | Norwalk | Connecticut | 06851 | — |
| University of Miami School of Medicine | Miami | Florida | 33136 | — |
| Oschner Clinic Foundation | New Orleans | Louisiana | 70121 | — |
| International Diabetes Center | Minneapolis | Minnesota | 55416 | — |
| Diabetes Care & Information Center of New York | Flushing | New York | 11365 | — |
| Diabetes Team Associated | New York | New York | 10016 | — |
| Endocrine Research - Physician's East PA | Greenville | North Carolina | 27834 | — |
| Your Diabetes Endocrine Nutrition Group | Mentor | Ohio | 44060 | — |
| Dallas Diabetes & Endocrine Center | Dallas | Texas | 75230 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Texas Diabetes Institute | San Antonio | Texas | 78207 | — |
| Diabetes & Glandular Disease Research Assoc PA | San Antonio | Texas | 78229 | — |
| Diabetes Care Center | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00754624, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 16, 2014 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00754624 live on ClinicalTrials.gov.